A new or recurrent stroke occurs in around 795,000 Americans every year and causes approximately 137,000 deaths. But new research published in the journal Neurology suggests a diet higher in protein may reduce stroke risk.
Thirty patients were enrolled at four sites across Europe and will be followed up using traditional assessments post-procedure and at 30 days to include MACE (death, stroke, MI), and ipsilateral stroke (31 days to 1 year). In addition, DW-MRI (Diffusion Weighted Magnetic Resonance Imaging) is being done pre and post procedure and at 30 days, as well as ultrasound examination at 30 days and 1 year on every patient.
Cuando un cónyuge, un compañero sentimental o un padre tiene migrañas crónicas, toda la familia sufre, según un nuevo estudio.
os accidentes cerebrovasculares (ACV) normalmente afectan a las mujeres a una edad avanzada, pero los médicos comienzan ahora enfocarse en ayudarlas a reducir su riesgo a una edad más temprana.
Las dietas ricas en proteína parecen reducir el riesgo de accidente cerebrovascular (ACV) de una persona, sobre todo si es proteína animal magra, como el pescado, sugiere un análisis reciente.
The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center (TMC), USA, has announced that the UTHealth Mobile Stroke Unit has successfully transported and helped save the life of its very first patient.
Keystone Heart has raised US$14 million in series B funding for cerebral protection devices. By protecting all brain territories, the TriGuard cerebral protection device is designed to minimise the risk of cerebral damage during transcatheter aortic valve implantation (TAVI) and other cardiovascular procedures.
Lately, flow diversion devices have been introduced to the clinical practice, offering endoluminal aneurysm occlusion by flow disruption. The most used flow diverter devices in the market, like Pipeline (Covidien) and Silk (Balt) as well as other new stents, are single-layer, low-porosity and self-expandable stents, forming high-coverage mesh that covers the aneurysm neck which simultaneously induces thrombosis of the aneurysm sac while preserving the patency of the adjacent small vessels. Alternatively, the Flow Re-direction Endoluminal Device (FRED; Microvention) is a novel flow diverter stent and has been in clinical use since 2012.
Fayyaz Ahmed, consultant neurologist, Hull and East Yorkshire Hospitals NHS Trust, UK, speaks to NeuroNews about transcranial magnetic stimulation, the systems being studied and the implications of National Institute for Health and Care Excellence (NICE) approval.
In a new study published online in the Journal of the American Heart Association, researchers at Columbia Engineering report that they have identified a new component of the biological mechanism that controls blood flow in the brain. Led by Elizabeth M C Hillman, associate professor of biomedical engineering, the team has demonstrated for the first time that the vascular endothelium plays a critical role in the regulation of blood flow in response to stimulation in the living brain.
Covidien has announced US Food and Drug Administration (FDA) approval of its Apollo Onyx delivery microcatheter—the first detachable tip micro catheter available in the USA. The new micro catheter is designed to mitigate the technical challenges of catheter retrieval during Onyx liquid embolic system embolisations of brain arteriovenous malformations.
Pulsar Vascular has announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for the PulseRider. The IDE allows Pulsar Vascular to begin a multicentre clinical trial in support of a humanitarian device exemption (HDE) to evaluate the PulseRider for US approval for wide neck aneurysms at or near a bifurcation of the basilar tip or carotid terminus. There are currently no devices approved by the FDA for this indication.
Previously, experience with the Enterprise vascular reconstruction device (Codman) has only been described in studies as a bailout procedure after primary stenting for acute ischaemic stroke with the Wingspan stent delivery system (Boston Scientific).
Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications. The findings appear in PLOS ONE.
InspireMD has announced that it has concluded enrolment in its CARENET (Carotid embolic protection study using MicroNet) clinical trial. The multi-specialty trial is assessing the peri-procedural safety and efficacy of CGuard systems in the treatment of carotid lesions. The acute procedural performance of the CGuard device was 100% successful for all of the 30 patients enrolled in the trial.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos